ecancer
ecancer is a UK charity which provides accessible, high-quality educational content, free to the global oncology community. Our mission is to raise the standards of care for cancer patients across the world through education.
- ESMO 2024
- WCLC 2024
- 2nd Annual BMC Chhattisgarh Cancer Conclave & 5th Choosing Wisely 2024
- TMC Kolkata Psycho-Oncology Congress
- ESMO GI 2024
- Best of ASCO® 2024 Miami Symposium
- ASCO® 2024
- EHA 2024
- ELCC 2024
- EAU 2024
- ASCO GU 2024
- ASCO GI 2024
- 2023
- 2022 and 2021
- Common Sense Oncology
- Lymphoma
- Leukemia
- Myeloma
- GYN Cancers
- Head&Neck Cancers
- GI Cancers
- Breast Cancers
- GU Cancers
- Lung Cancers
- Skin Cancers
- Basic Science
- Supportive & Palliative Care
- Business
- Events
Playback speed
10 seconds
Updated Data From the Phase 1/2 MajesTEC-1 Study: Evaluating Teclistamab in R/R MM
By
ecancer
FEATURING
Ajay Nooka
By
ecancer
FEATURING
Ajay Nooka
1,170 views
June 23, 2022
This video was recorded prior to the FDA approval of teclistamab-cqyv (TECVAYLI) for adult patients ...
read more ↘ with relapsed or refractory multiple myeloma who have received at least four prior lines of therapy.
↖ read less
read more ↘ with relapsed or refractory multiple myeloma who have received at least four prior lines of therapy.
↖ read less
Comments 0
Login to view comments.
Click here to Login